Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,011 public trials 1,828 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Recruiting

Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

NCT06634199

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Complejo Hospitalario Universitario Del Ferrol Ferrol, A Coruña, Spain
  • Hospital General Universitario de Alicante Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
View all 22 locations
View Trial Details
Recruiting

Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC

NCT06810609

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University Hospital Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Klinikum Stuttgart Stuttgart, Baden-Wurttemberg, Germany
  • University Hospital Gießen Giessen, Hesse, Germany
  • Johannes Wesling Klinikum Minden Mühlenkreiskliniken, Hämatologie und Onkologie Minden, North Rhine-Westphalia, Germany
View Trial Details
Recruiting

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

NCT05467748

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • VA Long Beach Healthcare System, Long Beach, CA Long Beach, California, United States
  • VA Northern California Health Care System, Mather, CA Sacramento, California, United States
  • VA San Diego Healthcare System, San Diego, CA San Diego, California, United States
  • VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States
View Trial Details
Recruiting

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

NCT06248515

Conditions
Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details

Related conditions